1. Home
  2. HURC vs PLYX Comparison

HURC vs PLYX Comparison

Compare HURC & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HURC

Hurco Companies Inc.

HOLD

Current Price

$16.99

Market Cap

107.3M

Sector

Industrials

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$6.74

Market Cap

271.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HURC
PLYX
Founded
1968
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.3M
271.8M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
HURC
PLYX
Price
$16.99
$6.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
16.9K
429.3K
Earning Date
03-06-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
8.59
N/A
EPS
N/A
N/A
Revenue
$178,554,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.19
$2.20
52 Week High
$21.46
$9.18

Technical Indicators

Market Signals
Indicator
HURC
PLYX
Relative Strength Index (RSI) 60.47 52.92
Support Level $16.29 $2.37
Resistance Level $17.00 $7.43
Average True Range (ATR) 0.60 1.16
MACD 0.26 -0.08
Stochastic Oscillator 80.62 33.33

Price Performance

Historical Comparison
HURC
PLYX

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

Share on Social Networks: